Skip to main content

and
  1. Article

    An HER2 DNA vaccine with evolution-selected amino acid substitutions reveals a fundamental principle for cancer vaccine formulation in HER2 transgenic mice

    Enhancement of endogenous immunity to tumor-associated self-antigens and neoantigens is the goal of preventive vaccination. Toward this goal, we compared the efficacy of the following HER2 DNA vaccine construc...

    Richard F. Jones, Joyce D. Reyes, Heather M. Gibson in Cancer Immunology, Immunotherapy (2019)

  2. No Access

    Article

    Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity

    Direct comparison and ranking of vaccine formulations in pre-clinical studies will expedite the identification of cancer vaccines for clinical trials. Two human ErbB-2 (Her-2) vaccines, naked DNA and whole cel...

    Paula J. Whittington, Olga Radkevich-Brown in Cancer Immunology, Immunotherapy (2009)

  3. No Access

    Protocol

    Murine Animal Model

    Experimental animal models are available for the development of new treatment. Murine animal models have particular advantages for comparative study to evaluate the efficacy and safety of different treatment m...

    Nobuyasu Nishisaka, Philo Morse, Richard F. Jones, Ching Y. Wang in Renal Cancer (2001)

  4. No Access

    Article

    Chemical carcinogenesis of the urinary bladder — a status report

    Cigarette smoking and certain types of occupational exposure to arylamines appear to be the main cause of human urinary bladder cancer. Little is known of the promotion of bladder cancer in humans, although th...

    Richard F. Jones, Maria Debiec-Rychter in Journal of Cancer Research and Clinical On… (1992)